A link between osteomyelitis and IL1RN and IL1B polymorphisms-a study in patients from Northeast Brazil
- PMID: 28682145
- PMCID: PMC5560221
- DOI: 10.1080/17453674.2017.1348439
A link between osteomyelitis and IL1RN and IL1B polymorphisms-a study in patients from Northeast Brazil
Abstract
Background and purpose - Treatment failure of osteomyelitis can result from genetic susceptibility, highlighting polymorphisms of the interleukin-1 (IL-1) family members, central mediators of innate immunity and inflammation. Polymorphisms are DNA sequence variations that are common in the population (1% or more) and represent multiple forms of a single gene. We investigated the association of IL1RNVNTR (rs2234663) and IL1B-511C > T (rs16944) polymorphisms with osteomyelitis development in patients operated on because of bone trauma. Patients and methods - 153 patients who fulfilled the inclusion criteria were enrolled from a referral public hospital for trauma. All the patients were followed up daily until hospital discharge and, after this, on an outpatient basis. Patients were treated with prophylactic antimicrobials and surgery according to traumatology service protocol. The IL1RNVNTR and the IL1B-511C > T polymorphisms were determined by PCR and PCR-RFLP, respectively. Results - The IL1RN*2/*2 genotype was associated (OR: 7; p < 0.001) with a higher risk of osteomyelitis and was also significantly associated with Staphylococcus aureus infection. The haplotypes (combination of different markers) *2-C and *2-T were also associated with osteomyelitis development. Interpretation - IL1B-511C > T and IL1RNVNTR polymorphisms were associated with osteomyelitis development, which may have implications for patients with bone traumas. These data may be relevant for new therapeutic strategies for this disease.
References
-
- Achyut B R, Srivastava A, Bhattacharya S, Mittal B.. Genetic association of interleukin-1β (-511 C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians. Clin Chim Acta 2007; 377 (1-2): 163–9. - PubMed
-
- Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, Meyer N, O’Mahony L, Palomares O, Rhyner C, Ouaked N, Schaffartzik A, van de Veen W, Zeller S, Zimmermann M, Akdis C A.. Interleus, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2011; 128 (4): 739. - PubMed
-
- Arend W P. The role of interleukin-1 receptor antagonist in the prevention and treatment of disease. Mod Rheumatol 2003; 13 (1): 1–6. - PubMed
-
- Balkwill F. Review. Cytokine amplification and inhibition of immune and inflammatory responses. J Viral Hepat 1997; 2: 6–15. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources